Sign In
Get Clay Free →

Suggestions

    Ron Renaud

    CEO at Translate Bio

    Ron Renaud is a distinguished professional with a strong educational background, including an MBA in Finance from the University of Southern California - Marshall School of Business and a BA in Psychology from Saint Anselm College, where he also studied at Saint John's High School.

    Ron Renaud currently holds the esteemed position of Chief Executive Officer at Translate Bio, showcasing exceptional leadership skills and business acumen in the biotechnology sector. He has a rich history of serving in various key roles in renowned organizations, such as serving as President & CEO at Idenix Pharmaceuticals and Chief Financial Officer and Chief Business Officer at the same company.

    Throughout his career, Ron Renaud has contributed significantly to the biopharmaceutical industry, with roles including Executive Vice President and CFO at Keryx Biopharmaceuticals, VP Equity Research & Biotechnology Sector Head at JP Morgan, and Managing Director positions at both Schwab Soundview and Bear Stearns.

    Ron Renaud's dedication to the field is further highlighted by his past roles at leading organizations like Amgen, where he served as a Senior Finance Analyst, Associate Manager, Investor Relations, and Clinical Research Associate. Additionally, his experience at the Dana-Farber Cancer Institute as a Biomedical Data Specialist/Facilitator/Research Assistant demonstrates his multifaceted expertise in the healthcare domain.

    In addition to his current role at Translate Bio, Ron Renaud has also been involved in various advisory capacities, having served as a Board Member at Atara Biotherapeutics, Ikena Oncology, Axial Biotherapeutics, Inc., Chimerix, Inc., Akebia Therapeutics, and PTC Therapeutics, Inc. He has also contributed his expertise as a Member of the Board at the American Liver Foundation New England Division.

    Ron Renaud
    Add to my network

    Location

    Lexington, Massachusetts, United States